{
    "2019-05-07": [
        [
            {
                "time": "",
                "original_text": "募資確定是投向科创？玻尿酸第一股遭上交所靈魂拷問",
                "features": {
                    "keywords": [
                        "募資",
                        "科创",
                        "玻尿酸",
                        "上交所"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技",
                        "醫療美容"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "江蘇北人等10家公司回覆首輪詢問 問詢",
                "features": {
                    "keywords": [
                        "江蘇北人",
                        "首輪詢問",
                        "科创板"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "製造業",
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "港股市值65億，擬148億估值登陸科创板！玻尿酸玩家\"昊海生物\"漂洋過海回大陸",
                "features": {
                    "keywords": [
                        "昊海生物",
                        "玻尿酸",
                        "科创板",
                        "估值"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技",
                        "醫療美容"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "上市是條荊棘路，一年內13家魯企終止IPO輔導",
                "features": {
                    "keywords": [
                        "上市",
                        "IPO",
                        "魯企"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "多行業"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}